A cell-based drug delivery platform for treating central nervous system inflammation

Mesenchymal stem cells (MSCs) are promising candidates for the development of cell-based drug delivery systems for autoimmune inflammatory diseases, such as multiple sclerosis (MS). Here, we investigated the effect of Ro-31-8425, an ATP-competitive kinase inhibitor, on the therapeutic properties of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Mol Med (Berl)
Päätekijät: Levy, Oren, Rothhammer, Veit, Mascanfroni, Ivan, Tong, Zhixiang, Kuai, Rui, Biasio De, Michael, Wang, Qingping, Majid, Tahir, Perrault, Christelle, Yeste, Ada, Kenison, Jessica E., Safaee, Helia, Musabeyezu, Juliet, Heinelt, Martina, Milton, Yuka, Kuang, Heidi, Lan, Haoyue, Siders, William, Multon, Marie-Christine, Rothblatt, Jonathan, Massadeh, Salam, Alaamery, Manal, Alhasan, Ali H., Quintana, Francisco J., Karp, Jeffrey M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8292974/
https://ncbi.nlm.nih.gov/pubmed/33398468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-020-02003-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia